Old Web
English
Sign In
Acemap
>
authorDetail
>
Ralf Schirrmacher
Ralf Schirrmacher
Cross Cancer Institute
Kinase
Chemistry
Molecular biology
In vivo
Radiochemistry
4
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model.
2021
Journal of Medicinal Chemistry
Justin J. Bailey
Melinda Wuest
Michael Wagner
Atul Bhardwaj
Carmen Wängler
Bjoern Wängler
John F. Valliant
Ralf Schirrmacher
Frank Wuest
Show All
Source
Cite
Save
Citations (0)
Tropomyosin receptor kinase inhibitors: an updated patent review for 2016 – 2019
2020
Expert Opinion on Therapeutic Patents
Justin J. Bailey
Carolin Jaworski
Donovan Tung
Carmen Wängler
Björn Wängler
Ralf Schirrmacher
Show All
Source
Cite
Save
Citations (7)
Development and biological evaluation of[18F]FMN3PA & [18F]FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging
2020
European Journal of Medicinal Chemistry
Noeen Malik
Rick Kornelsen
Siobhan McCormick
Nadine Colpo
Helen Merkens
Shreya Bendre
Francois Benard
Vesna Sossi
Ralf Schirrmacher
Paul Schaffer
Show All
Source
Cite
Save
Citations (0)
Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers
2017
Seminars in Nuclear Medicine
Ralf Schirrmacher
Björn Wängler
Justin J. Bailey
Vadim Bernard-Gauthier
Esther Schirrmacher
Carmen Wängler
Show All
Source
Cite
Save
Citations (21)
1